Experts discuss the future of bioinputs in Brazil

Held at the end of April, the workshop "Bioinputs and Innovation", promoted by Anpii Bio, brought together representatives from the industry, regulatory bodies and research institutions in Curitiba to discuss the future of the bioinputs sector in Brazil. Focusing on topics such as quality control, regulation and technological advances, the meeting was considered a milestone for promoting dialogue between different links in the production chain.

Experts from Embrapa, Anvisa, the Ministry of Agriculture and universities such as Esalq/USP and UnB participated in technical panels that addressed the production of microorganisms, validation of efficacy, innovation and the regulatory scenario. One of the central topics was the regulation of the Bioinputs Law, approved in December 2024, which establishes guidelines for the registration, commercialization and inspection of these products.

The day after the workshop, participants visited the facilities of the companies Agrocete and Go Genetic, references in the production of biological products, to learn more about the quality control protocols adopted.

Industry perspectives

According to Anpii Bio, the new legislation should boost the sector by streamlining processes and promoting sustainable practices without compromising safety and efficacy in the field. “Dialogue between industry, academia and government is essential to guarantee the quality and advancement of bioinputs,” highlighted Júlia Emanuela, director of the entity.

According to data from Anpii Bio, the sector generated R$5,7 billion in the last harvest and could reach R$9 billion by the end of the decade. Brazil already accounts for more than 11% of global consumption of bioinputs, with the potential to reach 16,4% by 2030. The entity continues to work to strengthen the sector and make biological products more accessible, safe and efficient for national agriculture.